1. Home
  2. CRIS vs SURG Comparison

CRIS vs SURG Comparison

Compare CRIS & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • SURG
  • Stock Information
  • Founded
  • CRIS 2000
  • SURG 2006
  • Country
  • CRIS United States
  • SURG United States
  • Employees
  • CRIS N/A
  • SURG N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • SURG Advertising
  • Sector
  • CRIS Health Care
  • SURG Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • SURG Nasdaq
  • Market Cap
  • CRIS 22.9M
  • SURG 58.6M
  • IPO Year
  • CRIS 2000
  • SURG N/A
  • Fundamental
  • Price
  • CRIS $1.54
  • SURG $2.79
  • Analyst Decision
  • CRIS Strong Buy
  • SURG Strong Buy
  • Analyst Count
  • CRIS 2
  • SURG 1
  • Target Price
  • CRIS $16.50
  • SURG $9.50
  • AVG Volume (30 Days)
  • CRIS 66.2K
  • SURG 80.2K
  • Earning Date
  • CRIS 11-13-2025
  • SURG 11-11-2025
  • Dividend Yield
  • CRIS N/A
  • SURG N/A
  • EPS Growth
  • CRIS N/A
  • SURG N/A
  • EPS
  • CRIS N/A
  • SURG N/A
  • Revenue
  • CRIS $11,405,000.00
  • SURG $36,461,935.00
  • Revenue This Year
  • CRIS $2.72
  • SURG $20.20
  • Revenue Next Year
  • CRIS $8.27
  • SURG $121.54
  • P/E Ratio
  • CRIS N/A
  • SURG N/A
  • Revenue Growth
  • CRIS 12.24
  • SURG N/A
  • 52 Week Low
  • CRIS $1.02
  • SURG $1.05
  • 52 Week High
  • CRIS $5.51
  • SURG $3.47
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 37.94
  • SURG 51.81
  • Support Level
  • CRIS $1.44
  • SURG $2.55
  • Resistance Level
  • CRIS $1.74
  • SURG $2.90
  • Average True Range (ATR)
  • CRIS 0.10
  • SURG 0.16
  • MACD
  • CRIS -0.02
  • SURG -0.01
  • Stochastic Oscillator
  • CRIS 25.93
  • SURG 75.00

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

Share on Social Networks: